In NSCLC, increasing levels of METTL3 significantly down-regulates DAPK2 mRNA and protein expressions and its mRNA stability by activating the NF-κB pathway, thus contributing to the NSCLC tumorigenesis (Jin et al., 2021). The gene discussed is METTL3; the disease is non-small cell lung carcinoma.